0001104659-23-077174.txt : 20230630 0001104659-23-077174.hdr.sgml : 20230630 20230630163632 ACCESSION NUMBER: 0001104659-23-077174 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230628 FILED AS OF DATE: 20230630 DATE AS OF CHANGE: 20230630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilmore Geoffrey CENTRAL INDEX KEY: 0001429407 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36464 FILM NUMBER: 231062295 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS STREET 2: 6 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGILE THERAPEUTICS INC CENTRAL INDEX KEY: 0001261249 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 COLLEGE ROAD EAST STREET 2: SUITE 310 CITY: PRINCETON STATE: NJ ZIP: 08540-6635 BUSINESS PHONE: 609-683-1880 MAIL ADDRESS: STREET 1: 500 COLLEGE ROAD EAST STREET 2: SUITE 310 CITY: PRINCETON STATE: NJ ZIP: 08540-6635 4 1 tm2320328-1_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-06-28 0 0001261249 AGILE THERAPEUTICS INC AGRX 0001429407 Gilmore Geoffrey 500 COLLEGE ROAD EAST, SUITE 310 PRINCETON NJ 08540 0 1 0 0 Chief Administrative Officer 0 Common Stock 2023-06-28 4 A 0 13500 0 A 13540 D Common Stock 2023-06-28 4 A 0 6716 0 A 20256 D Employee Stock Option (Right to Buy) 2.48 2023-06-28 4 A 0 4500 0 A 2033-06-27 Common Stock 4500 4500 D These shares represent restricted stock units ("RSUs") which were granted on June 28, 2023. The RSUs will vest in four equal installments over four years upon the anniversary of the grant, such that the RSUs will be fully vested on June 28, 2027. On April 10, 2023, the Issuer completed a one-for-fifty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split. These shares represent RSUs that were granted on June 28, 2023, which will vest and be settled in common stock on June 28, 2024. This option was granted on June 28, 2023. 25% of the shares subject to the stock option vest on June 28, 2024, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on June 28, 2027. /s/ Geoffrey P. Gilmore 2023-06-30